Anticancer Drugs 2019 Jan;30(1):38-45.doi: 10.1097/CAD.0000000000000687.
2019-01-25Anticancer Drugs 2019 Jan;30(1):38-45.doi: 10.1097/CAD.0000000000000687.Increased miR-203-3p and reduced miR-21-5p synergistically inhibit proliferation, migration, and invasion in esophageal cancer cells.